Immune shielding of viral vectors via capsid engineering with genetically encoded zwitterionic peptides.

Saved in:
Bibliographic Details
Title: Immune shielding of viral vectors via capsid engineering with genetically encoded zwitterionic peptides.
Authors: Lu SC; Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA., Ma OX; The Hormel Institute, University of Minnesota, Austin, MN 55912, USA., Anwar AA; Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA., Ratkov D; Virology and Gene Therapy Track, Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN 55905, USA., Bhandari J; The Hormel Institute, University of Minnesota, Austin, MN 55912, USA., Montiel-Garcia DJ; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Hansen MJ; Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA., Barry ME; Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA., Reddy VS; The Hormel Institute, University of Minnesota, Austin, MN 55912, USA.; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA., Barry MA; Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA.; Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Source: Molecular therapy. Advances [Mol Ther Adv] 2026 Feb 13; Vol. 34 (1), pp. 201694. Date of Electronic Publication: 2026 Feb 13 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Country of Publication: United States NLM ID: 9919257804006676 Publication Model: eCollection Cited Medium: Print ISSN: 3117-387X (Print) Linking ISSN: 3117387X NLM ISO Abbreviation: Mol Ther Adv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:3117-387X
DOI:10.1016/j.omta.2026.201694